ARCHIVES

ODAC Meeting: Further Restrictions Likely On ESA Use; Changes Advocated by ODAC May Cut Market By 40-50 Percent.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

Science Policy: Silicone Breast Implants Don’t Cause Disease

June 25, 1999

Two Breast Cancer Treatments Show Similar Benefit In Trial

December 30, 2005

Also MSKCC picks David Kissane to succeed Jimmie Holland as chairman of psychiatry and behavioral sciences.

October 24, 2003

Polymer Platinate Begins Testing In Phase I Trial.

September 29, 2000

Scripps, Sandoz Deal Becomes Case Study As NI Rethinks Sponsored Research

January 28, 1994

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

October 28, 2005